ReproCELL

Stem Cell Innovation

 Products & Services

 Request a Sample  Newsletter  Contact us

News & Topics

2016.09.20 MEDIAAlvetex wins CV Technology Innovator Awards 2016

ReproCELL is proud to announce its groundbreaking 3D cell culture technology Alvetex has been awarded the Corporate Vision Technology Innovator Award 2016. Read the full interview with Prof. Dr. Stefan Przyborski, ReproCELL Europe’s Chief Scientific Officer and inventor of Alvetex, here: http://reinnervate.com/reprocell-europe-wins-cv-tech-innovator-awards-2016-alvetex/

2016.06.14 ISSCR 2016 Annual Meeting

We will exhibit and presentat a poster at ISSCR 2016 Annual Meeting, San Francisco, USA. We will like to welcome you to stop by our booth and posters. 【 ISSCR 2016 Annual Meeting 】 ■URL: http://www.isscr.org/home/annual-meeting/san-francisco-2016 ■Date: JUNE 22-25, 2016 ■Place: San Francisco, America ■Booth:   ・Date: JUNE 22-25, 2016   ・Booth No.: 1608 ■POSTER   <Ⅰ>   ・Date & Time: JUNE 22, 2016 6:30PM-7:30PM   ・Poster No.: Poster W1093   ・Title: ”Improvement of human iPS cell-derived hepatocyte functionality using 3D culture systems”   ・Presenter: ReproCELL, Inc. Zachary Yu Ching Lin   <Ⅱ>   ・Date & Time: JUNE 22, 2016 7:30PM-8:30PM   ・Poster No.: Poster W2064   ・Title: ”Non-modified RNAs for the derivation of clinically relevant iPS cell lines from adult […]

2016.06.07 11th International ISSX Meeting

We make the presentation a poster at 11th International ISSX Meeting at Busan, Korea. Please stop by at our poster if you attend to the meeting. 【11th International ISSX Meeting】 ■URL: http://issxbusan2016.org/ ■Date: June 12-16, 2016 ■Place: Busan, Korea ■POSTERⅠ   ・Date: June 15, 2016 12:15~13:00 Poster session 2   ・Location: Exhibit Hall (Grand Ballroom – 3F)   ・Poster No.: P52   ・Title: “Stabilized and Enhanced CYP450 Enzyme Activity in Cultured Human Primary Hepatocytes is         Conferred by ReproHP Medium”   ・Host: Sales & Marketing Department Paul CIZDZIEL & Wirtz Julia ■POSTERⅡ   ・Date: June 15, 2016 12:15~13:00 Poster session 2   ・Location: Exhibit Hall (Grand Ballroom – 3F)   ・Poster No.: P232   ・Title: “Improving the prediction of oral bioavailability using fresh […]

2013.05.16 MEDIAWebinar: iPSC derived Cells & hiPSC/ES media June 4th 2013– 10 AM CEST

Webinar: iPSC derived Cells & hiPSC/ES media June 4th 2013– 10 AM CEST Please register from here; https://attendee.gotowebinar.com/register/7334590631056470272

2013.03.22 MEDIAReproCELL’s iPS cell technology featured in NHK World news

ReproCELL’s iPS cell technology featured in NHK World news http://www3.nhk.or.jp/nhkworld/english/movie/feature201303211118.html

2012.10.26 MEDIAArticle on human ES/iPSC-derived Cardiomyocytes published

An article written jointly by Kyoto University and ReproCELL was published in Cell Rep. 2012 Nov 29;2(5):1448-60.. “Small Molecule that Promotes Cardiac Differentiation of Human Pluripotent Stem Cells under Defined, Cytokine- and Xeno-free Conditions”

2012.10.11 MEDIAReproCELL’s iPS cell business introduced in Japanese TV news programs

ReproCELL’s iPS cell business was widely introduced in Japanese TV news on Prof. Shinya Yamanaka’s €Nobel Prize.

2012.01.18 MEDIAGEN article introduced ReproCELL’s technology

ReproCELL’s iPS cell-derived cardiomyocytes, neurons and hepatocytes were introduced in Genetic Engineering & Biotechnology News (GEN). Jan 15, 2012 (Vol. 32, No. 2) Stem Cell Applications Hasten into the Clinic

2010.07.01 MEDIAReproCELL featured in Genetic Engineering & Biotechnology News

An article in Genetic Engineering & Biotechnology News, “Pharma’s R&D Focus Shifting to Stem Cells -Investors’ Interest in These Cells Increases as Scientists Continue to Unleash Their Potential” introduces ReproCELL’s new cardiotoxicity assay using iPSCs, QTempo, as well as its neural stem cell research. Read the article

2016.06.22 ISSCR 2016 Annual Meeting San Francisco, America Exhibition, Poster Presentation, INNOVATION SHOWCASE
2016.06.12 11th International ISSX Meeting ISSX at Busan、Korea Poster Presentation
2014.07.12 AAIC 2014 Bella Center Convention Center, Copenhagen Exhibition, Poster Presentation
2012.07.13 ISSCR2012 ISSCR2012 at Yokohama Poster Presentation
2012.06.18 BIO BIO 2012 at Boston Exhibition
2012.02.4 SLAS, SOT, ISSCR SLAS2012 at San Diego Exhibition
2011.09.19 Miptec MipTec at Basel Exhibition
2016.09.20 MEDIAAlvetex wins CV Technology Innovator Awards 2016

ReproCELL is proud to announce its groundbreaking 3D cell culture technology Alvetex has been awarded the Corporate Vision Technology Innovator Award 2016. Read the full interview with Prof. Dr. Stefan Przyborski, ReproCELL Europe’s Chief Scientific Officer and inventor of Alvetex, here: http://reinnervate.com/reprocell-europe-wins-cv-tech-innovator-awards-2016-alvetex/

2013.05.16 MEDIAWebinar: iPSC derived Cells & hiPSC/ES media June 4th 2013– 10 AM CEST

Webinar: iPSC derived Cells & hiPSC/ES media June 4th 2013– 10 AM CEST Please register from here; https://attendee.gotowebinar.com/register/7334590631056470272

2013.03.22 MEDIAReproCELL’s iPS cell technology featured in NHK World news

ReproCELL’s iPS cell technology featured in NHK World news http://www3.nhk.or.jp/nhkworld/english/movie/feature201303211118.html

2012.10.26 MEDIAArticle on human ES/iPSC-derived Cardiomyocytes published

An article written jointly by Kyoto University and ReproCELL was published in Cell Rep. 2012 Nov 29;2(5):1448-60.. “Small Molecule that Promotes Cardiac Differentiation of Human Pluripotent Stem Cells under Defined, Cytokine- and Xeno-free Conditions”

2012.10.11 MEDIAReproCELL’s iPS cell business introduced in Japanese TV news programs

ReproCELL’s iPS cell business was widely introduced in Japanese TV news on Prof. Shinya Yamanaka’s €Nobel Prize.

2012.01.18 MEDIAGEN article introduced ReproCELL’s technology

ReproCELL’s iPS cell-derived cardiomyocytes, neurons and hepatocytes were introduced in Genetic Engineering & Biotechnology News (GEN). Jan 15, 2012 (Vol. 32, No. 2) Stem Cell Applications Hasten into the Clinic

2010.07.01 MEDIAReproCELL featured in Genetic Engineering & Biotechnology News

An article in Genetic Engineering & Biotechnology News, “Pharma’s R&D Focus Shifting to Stem Cells -Investors’ Interest in These Cells Increases as Scientists Continue to Unleash Their Potential” introduces ReproCELL’s new cardiotoxicity assay using iPSCs, QTempo, as well as its neural stem cell research. Read the article

List of News & TopicsList of MediaList of Society presentations and exhibitors

Investor Relations

2016.11.21 investor-relationsAnnouncement on the initiation of a new business from the collaboration and commercialization agreement with Steminent Biotherapeutics Inc. for cell therapy

collaboration-and-commercialization-agreement-with-steminent-biotherapeutics

2015.11.24 investor-relationsRegarding the synergy effect of making Biopta Limited a wholly-owned subsidiary

Regarding the synergy effect of making Biopta Limited a wholly-owned subsidiary(1) Regarding the synergy effect of making Biopta Limited a wholly-owned subsidiary(2)  

2015.11.18 investor-relationsNotice concerning the publication of a paper concerning “3D culture model construction of mouse neurons” from a company in our group in the international neuroscience journal ‘Neuroscience Letters’

Notice concerning the publication of a paper concerning “3D culture model construction of mouse neurons” from a company in our group in the international neuroscience journal ‘Neuroscience Letters’

2015.11.16 investor-relationsA Joint Development with the National Cancer Cente: Information Regarding the Sale of “ReproHP Medium,” a Culture Fluid for Human Primary Liver Cells with High Levels of Functionality

A Joint Development with the National Cancer Cente: Information Regarding the Sale of “ReproHP Medium,” a Culture Fluid for Human Primary Liver Cells with High Levels of Functionality

2015.11.04 investor-relationsNotice of Passage of Examination for United States Patent Application Concerning Amplification Method of Hematopoietic Stem Cells

Notice of Passage of Examination for United States Patent Application Concerning Amplification Method of Hematopoietic Stem Cells

2015.10.19 investor-relationsThe ReproCELL Group announces publication of a research report on “3D Skin Model Construction,” submitted to the International Scientific Journal “Molecular Cancer Therapeutics” by this corporate group and others.

20151019_The ReproCELL Group announces publication of a research report on “3D Skin Model Construction,” submitted to the International Scientific Journal “Molecular Cancer Therapeutics”

2015.10.14 investor-relationsThe ReproCELL Group announces publication of a paper on its state-of-the-art RNA Reprogramming technology in Human Gene Therapy, an international journal.

The ReproCELL Group announces publication of a paper on its state-of-the-art RNA Reprogramming technology in Human Gene Therapy, an international journal.

2015.09.24 investor-relationsJoint Announcement with Ajinomoto Co., Inc.Notification of the Beginning of Sales of StemFIT® AK02N High-Performance Culture Solution for Regenerative Medicine Use Human iPS Cells

Joint Announcement with Ajinomoto Co., Inc.Notification of the Beginning of Sales of StemFIT® AK02N High-Performance Culture Solution for Regenerative Medicine Use Human iPS Cells

2015.09.08 investor-relationsAnnouncement: ReproCELL concludes license agreement with Keio University for the exclusive sale of myocardial cells derived from disease-type (long QT syndrome, a congenital heart disease) iPS cells

ReproCELL concludes license agreement with Keio University for the exclusive sale of myocardial cells derived from disease-type (long QT syndrome, a congenital heart disease) iPS cells

2015.08.26 investor-relationsJoint Press Announcement with Institute for Frontier Medical Sciences, Kyoto University: New high-performance cryopreservation solution for human ES/iPS cells used in regenerative medicine, Notice of the commencement of sales of “ReproCryo DMSO free”

Joint Press Announcement with Institute for Frontier Medical Sciences, Kyoto University: New high-performance cryopreservation solution for human ES/iPS cells used in regenerative medicine, Notice of the commencement of sales of “ReproCryo DMSO free”

Investor Relations of all

group companies